BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9551416)

  • 1. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K; Würzner R; Kronenberg F; Oppermann M; König P
    Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
    Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
    Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in diabetic ketoacidosis and its treatment.
    Jerath RS; Burek CL; Hoffman WH; Passmore GG
    Clin Immunol; 2005 Jul; 116(1):11-7. PubMed ID: 15925827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate.
    Haag-Weber M; Mai B; Deppisch R; Göhl H; Hörl WH
    Clin Nephrol; 1994 Apr; 41(4):245-51. PubMed ID: 8026120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement system is not activated in primary biliary cirrhosis.
    Gardinali M; Conciato L; Cafaro C; Crosignani A; Battezzati PM; Agostoni A; Podda M
    Clin Immunol Immunopathol; 1998 Jun; 87(3):297-303. PubMed ID: 9646840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
    Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
    Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
    J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inborn deficiency of complement C4A and C4B isotypes in persons infected with Chlamydia].
    Kozlov LV; Skirda TA; Skorokhodova TG; Lakhtin VM; Batalova TN; Guzova VA
    Vopr Med Khim; 2001; 47(1):103-10. PubMed ID: 11385992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.
    Gianella-Borradori A; Borradori L; Schneider PM; Gautier E; Späth PJ
    Clin Immunol Immunopathol; 1990 Apr; 55(1):41-55. PubMed ID: 2306879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antibodies enhance alternative complement pathway activation by cuprophane.
    Maillet F; Kazatchkine MD
    Nephrol Dial Transplant; 1991; 6(3):193-7. PubMed ID: 1714061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-membrane interaction: C3a, an indicator of biocompatibility.
    Ivanovich P; Hammerschmidt DE; Chenoweth D; Klinkmann H; Vidovic D
    Life Support Syst; 1985; 3 Suppl 1():394-403. PubMed ID: 3879953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.